uniQure to Host Investor Day in New York City on October 15, 2015
October 07 2015 - 8:46AM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today
announced that it will be hosting an Investor Day and simultaneous
webcast in New York City on October 15, 2015, starting at 8:30 a.m.
uniQure management and invited guests will discuss the Company's
strategy, clinical programs and uniQure's vision of how gene
therapy will change the future of medicine.
Event
Date: October 15, 2015
Time: 8:30 a.m. – approx. 12:00 p.m. ET
Venue: The Benjamin Hotel, 125 E. 50th Street, New York City,
NY
Speakers
- Jörn Aldag, Chief Executive Officer, uniQure
- Deya Corzo, M.D., Senior Vice President, Research and
Development, Liver/Metabolism, uniQure
- Christian Meyer, M.D., Ph.D., Chief Medical Officer,
uniQure
- Patrick Most, M.D., Managing Director, uniQure GmbH
- Harald Petry, Ph.D., Chief Scientific Officer, uniQure
- Charles W. Richard, M.D., Ph.D., Senior Vice President,
Research and Development, Neuroscience, uniQure
- Chester B Whitley, Ph.D., M.D., Principal Investigator,
Lysosomal Disease Network
Analysts and qualified investors who would like to register or
learn more about the event should contact Blair Atkinson of
MacDougall Biomedical Communications at +1 812 454 6257 or +1 781
235 3060 or batkinson@macbiocom.com. Registration is required as
space is limited.
Webcast
To access the webcast, log on
http://edge.media-server.com/m/p/nroin5kw or go to the "Events"
section on the "Media" page of uniQure's website, at
http://www.uniqure.com/news/calendar-of-events. A replay of the
webcast will be available on uniQure's website for at least 30 days
following the event.
About uniQure
uniQure is delivering on the promise of gene therapy – single
treatments with potentially curative results. We are leveraging our
modular and validated technology platform to rapidly advance a
pipeline of proprietary and partnered gene therapies to treat
patients with CNS, liver/metabolic and cardiovascular diseases.
www.uniQure.com
CONTACT: uniQure:
Aicha Diba
Investor Relations
Direct: +31 20 240 6100
Main: +31 20 566 7394
a.diba@uniQure.com
Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494
gschweitzer@macbiocom.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024